
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Two recent studies presented at the Conference on Retroviruses and Opportunistic Infections highlight novel approaches to combat rising STI rates.
